Close Menu

NEW YORK (GenomeWeb) – India's Strand Life Sciences today announced it closed a financing round that raised $13 million.

Private equity firm Quadria Capital led the investment. HealthQuad Fund and Heritas Venture Fund also participated.

The financing will be used to help Strand's growth initiatives, and the support of Quadria "will help launch Strand into its next phase of growth and into an era where data analytics and molecular measurements together change diagnosis and treatment paradigms," Strand CEO Ramesh Hariharan said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Aug
12
Sponsored by
Truvian

Antibody testing is expected to play an important role in the management of the COVID-19 pandemic. 

Aug
18

As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.